As part of ongoing research on natural products derived from medicinal plants for enzyme inhibition, known dibenzoyl derivatives (1-3, 11 and 20), pterocarpans (4, 15 and 19), flavanones (5, 7, 10, 12-14, 18, 21-24, 26, 27, 29, 31-33, 35, 36, and 38-46), flavones (6, 16, 28, 30 and 37), isoflavones (8 and 17), furocoumarins (9), and chalcones (25 and 34) have been tentatively identified within fractions of Sophora flavescens roots (SFR) using the ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QTof-MS) technique. The extract and column fractions inhibited indoleamine 2,3-dioxygenase (IDO) and monoamine oxidases (MAOs) differently depending on the metabolite groups. The majority of rich fractions were shown to have residual activities of 49-59% at 10 g/mL (IDO) and 11.7-34.9% at 50 g/mL (MAOs) or below. In the total ion current (TIC) chromatogram, significant markers for the metabolites of the bioactive-guided fractions were identified; pterocarpans (4, 15 and 19), flavanones (5, 10, 12-14, 18, 21-23, 26, 29, 31-33, 35, 36, and 38-46), isoflavones (8 and 17), furocoumarins (9), dibenzoyl derivatives (11 and 20), flavones (16, 28, 30 and 37), and chalcones (25 and 34) were evaluated among forty-six analyzed metabolites. Possible bioactive markers could be deduced using a data library and previous references, and information regarding spectroscopic characterization and optimal target metabolites was obtained.
Recently, a rapid method to identify metabolites of enzyme activity from complex mixtures of plant extracts or fractions using ultrahigh performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QTof-MS) [1] . Interestingly, UPLCQTof-MS studies have utilized multiple detection and quantification strategies to assess numerous metabolites from natural products. Recently, significant plant metabolite libraries from Euphorbia supina, Camellia sinensis, and Agastache rugosa (Fisch. & C.A.Mey.) have been reported using UPLC-QTof-MS [2] [3] [4] . To characterize the profile of bioactive metabolites, QTof-MS is now widely used in natural products studies and is accepted as one of the best analytical techniques for this type of research [5] . According to the results obtained from previous reports, Sophora flavescens contains many metabolites, namely, chalcones, flavanol, flavanones, and pterocarpans, suggesting that it could have therapeutic potential in the prevention of various diseases, such as asthma, fever, dysentery, hematochezia, oliguria, vulvar swelling, jaundice, eczema, inflammatory disorders, ulcers and diabetes mellitus [6] .
Although some reports have arisen regarding the pharmacological inhibitory activities of S. flavescens extracts, none of these have been able to elucidate the fundamental connection between activity and the minor metabolites present in the fractions. This plant has been widely investigated with regard to its constituents and biological effects, metabolite profiles from UPLC-based profiling from active fractions have not been evaluated. Therefore, the aim of this study was to trace the metabolites of column fractions in order to elucidate the profile of bioactive metabolites. The focus of this research was chosen in view of the fact that monoamine oxidases (MAOs) and indoleamine 2,3-dioxygenase (IDO) are key factors linking chronic metabolic disease and therapeutic approaches that consists of enzyme modulatory actions. Study of the metabolites' inhibitory activity on MAOs and IDO enzymes was also motivated by the ease, simplicity, and effectiveness of such an approach.
The metabolites of S. flavescens showed potent enzyme inhibitory activities with IC50s of 2.6-63.7 M (BACE1), 37.0-68.0 M (-glucosidase), 45.0-85.0 M (-amylase), 17.5-26.9 M (low density lipoprotein-antioxidant), and 12.0-56.5 M (human acyl-CoA: cholesterol acyltransferases), indicating the presence of metabolites that may by therapeutic against chronic metabolic diseases [7] [8] [9] [10] [11] [12] . Furthermore, the column fractions showed the lowest inhibition value against IDO (SFR Fr.6-8, 55-59% at 10 g/mL) as well as MAOs (SFR Fr. 3, 4, and 7, MAO-A 17.5-34.9% and MAO-B 11.7-19.6% at 50 g/mL) ( (17) , chalcones (25 and 34) and flavones (30 and 37), were found to be major components of SFR Frs. 3-4 and 6-8 based on the UPLC-PDA-QTof-MS chromatograms. As presented in Fig. 1 , total ion current (TIC) chromatographic separation of the metabolites was achieved within 11 min, although some metabolite overlapping occurred. Forty-six metabolites were tentatively identified by High Resolution Mass Spectrometry (HRMS) analysis. The mass (MS) spectra of all metabolites were carefully compared in the context of the previous Sophora genus (Fabaceae) literature, including the experimental t R , UV, m/z values, High-resolution electrospray ionization mass spectrometry (HRESIMS) data, error ppm, Tandem mass spectrometry (MS 2 ), and molecular formulae data (sub. 1) [6, 15, 16, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . In S. flavescens, these metabolites are structurally diverse, containing alkaloids, flavanone, flavanol, flavone, isoflavone, pterocarpan, chalcone, furocoumarin, and dibenzoyl derivatives as substituents, which are encountered with prenyl, lavandulyl or glycoside groups [17, 18, 21, 24-29, 35, 38-40] . Tentative identification each metabolite focuses on key metabolites that contributed in bioactive fractions to enzyme inhibitory activity ( [13, 14, 22, 26] . MS spectral data for all extracts and SFR Fr. 4 (Fig. 1C) were obtained for the main compounds 10, 12, 17, 18, 20, 21, 22, and 23, which were tentatively identified as a kurarinol (10) [22, 23, 25, 27, 29] . The main components in SFR Fr.6 and 7 ( Fig. 1D−E) , such as kuraridin (25) , kushenol C (30), (2S)-2'-methoxykurarinone (31), kushenol F (32), and kushenol L (33), were also found in similar amounts, which is consistent with previous study [13, 22, 23, 29] . The minor metabolites found were kurarinone isomers (26) [22, 23, 33] . The SFR Fr.8 was the last to be analyzed. After MS detection (Fig. 1F) , the chromatogram exhibited eleven metabolites at t R values of 7.22 and 9.78 min, which were identified as kuraridin isomers (34), sophoranodichromanes C (37), Isokurarinone (38) , kushenol E (39), kurarinone (40) , kushenol M isomer (41) , kushenol M (42), kushenol A (43), sophoraflavanone G (44), (2S)-2′-methoxy kurarinone isomers (45), and kushenol B (46), the most common prenylated flavonoids found in S. flavescens [13, 22-24, 29, 34, 35, 37] . Minor metabolites appeared and included sophoraflavanone G derivate (35) These analysis data validate a report in a previous paper in which the main compounds of a S. flavescens bioactivity-guided fraction were determined [7] [8] [9] [10] [11] [12] . Previous results have revealed some components and effects on MAOs of S. flavescens SFR Fr. 2, 4, 7, and 8 [10] . Although many reports have arisen regarding the broad biological activity of S. flavescens, these have still not been fully characterized, which prompted us to analyze the secondary metabolites. In the case of immunotherapy diseases, IDO, an intracellular cytosolic enzyme that is involved in the degradation of Trp to N-formylkynurenine, has been regarded as an important target for cancer therapeutics based on immune tolerance [38] . Therefore, we analyzed the overall composition of metabolites with potential activity toward MAOs and IDO via medium-pressure liquid chromatography. Furthermore, we closely analyzed the minor metabolites isolated by column partition systematically with m/z profiles extracted using MassLynxTM software (version 4.1, Waters, Manchester, UK). Due to its potency, subsequent bioactivity-guided fractionation of SFR fractions led to 12 minor metabolites, which were identified as isoflavone (8), furocoumarin (9), flavanones (13, 14, 26, 29, 35 and 36) , pterocarpans (15 and 19) and flavones (16 and 28). Active ingredients were found to include not only formononetin 17, sophoraflavanone B 22, and kushenol F 32 (main metabolites) but also genistein 8, (-)-4-hydroxy-3-methoxy-8,9-methylenedioxypterocarpan 15, and (-)-maackiain 19 (minor metabolites) when the inhibitory activity toward MAOs was determined by the IC50s 0.68-85.8 M. Kushenol T 13 [7] and kushenol E 39 [10] were not found to be targets for Alzheimer's disease. In addition, imperatorin 9 inhibited COX-1, which is associated with Parkinson's disease [19] . Moreover, we tentatively identified minor metabolites 14, 16, 26, 28, 29, 35, and 36 that were not detected as targets for the MAOs enzyme. Furthermore, to investigate the inhibitory activity of SFR fractions against IDO, we examined the column partitions. The most predominant effects were shown in SFR Fr.6-8 (55-59% at 10 g/ml). According to the results shown above, metabolites were found from SFR Fr.6-8, suggesting that those main and/or minor metabolites might be significant components. As presented in Table 1 , all metabolites from SFR Frs. 6-8 exhibited significant components in IDO inhibition. The reported study results were deficient in information regarding the effectiveness of the metabolites because IDO had not yet been studied. Those target enzymes (MAOs and IDO) and the enzyme kinetics of minor metabolites need to be further investigated. Therefore, in this study, standardized information for the metabolites provided the optimal conditions for SFR products use through using standard operating procedures (SOP) for MPLC.
Experimental
Chemicals and materials: Methanol was purchased from Honeywell International Inc. (Moris plains, USA). Acetonitrile of HPLC grade was from Merck (Darmstadt, Germany). Ultra-purity water was prepared using a water purification system (Milli-Q Academic, Merck Millipore). kushenol A, kushenol B, kushenol E, Park et al. kushenol F, kushenol H, kushenol K, kushenol L, kushenol M, kushenol N, genistein, sophoraflavanone G, sophoraflavanone B, noranhydroicaritin, formononetin, norkurarinol, maackiain, and 4-hydroxy-3-methoxy-8,9-methylenedioxypterocarpan as reference standards were provided by Korea Research Institute of Bioscience and Biotechnology (KRIBB). Roots of Sophora flavescens Ait. were purchased from a Jin Heung geon jae oriental medicine wholesale store (Seoul, Korea).
Sample preparation: Preparation procedures on the extract and fractionation were done by the method of Lee et al. [10] .
Instrumentation and analytical conditions:
The profiling analyses were performed on the ACQUITY UPLC TM System (Waters, Milford, USA) coupled to Micromass QTof Premier TM mass spectrometer (Waters). The gradient condition (solvent: water (A), acetonitrile (B) with 0.1% formic acid) was 0-1 min 25% B; 1-11 min 25-80% B; 11-12 min 80-100% B; 12-13.40 min 100% B; 13.40-13.50 min 100-25% B; 13.50-15 min 25% B. The flow rate was 0.4 mL/min, and an ACQUITY BEH C18 column (2.1 × 100 mm, 1.7 m, Waters) was used. The QTof-MS was operated in negative ion mode with the following conditions: source temperature 100 °C, desolvation temperature 350 °C, capillary voltage 2.3 kV, cone voltage 50 V. Leucine-enkephalin (400 pg/mL) was used as the reference compound (m/z 556.2771 in the positive mode and m/z 554.2615 in the negative mode) at a flow rate of 2 L/min. Accurate mass, MS/MS, and elemental composition were calculated using the MassLynx software (Waters) incorporated into the instrument.
Enzyme inhibitory activity:
The inhibitory effects of the samples toward MAOs and IDO were measured using a colorimetric method as described by Lee et al. [40] and Takikawa [41] , respectively. Briefly, the in vitro inhibition assays of MAOs were run in 50 mM sodium phosphate buffer, pH 7.4 (reaction buffer). 0.06 mM kynuramine (Km = 0.036 mM) and 0.6 mM benzylamine (Km = 0.27 mM) were used as substrates at 316 nm for 20 min and 250 nm for 30 min, respectively. In the case of IDO, the 200-microliter reaction mixture contained potassium phosphate buffer (50 mM, pH 6.5), ascorbic acid (20 mM), purified-recombinant hIDO1 (20 g/ml), methylene blue (10 mM), and L-tryptophan (200 M) as the substrate. The fractions were diluted in DMSO and transferred to a 96-well plate. The reaction was conducted at 37 °C for 1 hour and stopped by adding 40 L 30% trichloroacetic acid and heating at 65°C for 15 min. The plate was centrifuged at 4000 RPM for 15 min. Subsequently, 125 L of supernatant was transferred to a new 96-well plate, mixed with 125 L of 2% p-dimethylaminobenzaldehyde in acetic acid and then read using a Versamax (Molecular Devices) ELISA plate reader at 480 nm.
